Delayed
Japan Exchange
02:00:00 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
18,440
JPY
|
-3.05%
|
|
+1.43%
|
+114.67%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
18,053
|
16,725
|
19,476
|
27,325
|
43,787
|
93,996
|
-
|
-
|
Enterprise Value (EV)
1 |
16,088
|
14,222
|
13,832
|
19,574
|
34,723
|
93,996
|
93,996
|
93,996
|
P/E ratio
|
15.2
x
|
12.4
x
|
11
x
|
10.7
x
|
11.9
x
|
20.4
x
|
23.5
x
|
21.4
x
|
Yield
|
2.12%
|
2.74%
|
3.14%
|
3.45%
|
3.14%
|
1.74%
|
1.74%
|
1.74%
|
Capitalization / Revenue
|
1.07
x
|
0.99
x
|
0.96
x
|
1.07
x
|
1.66
x
|
2.85
x
|
3.13
x
|
2.85
x
|
EV / Revenue
|
1.07
x
|
0.99
x
|
0.96
x
|
1.07
x
|
1.66
x
|
2.85
x
|
3.13
x
|
2.85
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
32,528,763
x
|
-116,146,286
x
|
-
|
284,640,095
x
|
18,728,342
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
-0%
|
-
|
0%
|
0%
|
-
|
-
|
-
|
Price to Book
|
0.73
x
|
0.65
x
|
0.72
x
|
0.94
x
|
1.37
x
|
2.68
x
|
2.51
x
|
2.33
x
|
Nbr of stocks (in thousands)
|
5,100
|
5,099
|
5,098
|
5,098
|
5,097
|
5,097
|
-
|
-
|
Reference price
2 |
3,540
|
3,280
|
3,820
|
5,360
|
8,590
|
18,440
|
18,440
|
18,440
|
Announcement Date
|
3/27/20
|
2/3/21
|
2/3/22
|
2/3/23
|
2/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
16,854
|
16,859
|
20,354
|
25,564
|
26,413
|
33,000
|
30,000
|
33,000
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
2,057
|
2,185
|
2,709
|
3,756
|
5,296
|
6,800
|
6,000
|
6,500
|
Operating Margin
|
12.2%
|
12.96%
|
13.31%
|
14.69%
|
20.05%
|
20.61%
|
20%
|
19.7%
|
Earnings before Tax (EBT)
|
1,812
|
1,989
|
2,592
|
3,599
|
5,200
|
-
|
-
|
-
|
Net income
1 |
1,191
|
1,343
|
1,773
|
2,562
|
3,672
|
4,600
|
4,000
|
4,400
|
Net margin
|
7.07%
|
7.97%
|
8.71%
|
10.02%
|
13.9%
|
13.94%
|
13.33%
|
13.33%
|
EPS
2 |
233.6
|
263.5
|
347.9
|
502.7
|
720.5
|
902.5
|
784.8
|
863.3
|
Free Cash Flow
|
555
|
-144
|
-
|
96
|
2,338
|
-
|
-
|
-
|
FCF margin
|
3.29%
|
-0.85%
|
-
|
0.38%
|
8.85%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
46.6%
|
-
|
-
|
3.75%
|
63.67%
|
-
|
-
|
-
|
Dividend per Share
2 |
75.00
|
90.00
|
120.0
|
185.0
|
270.0
|
320.0
|
320.0
|
320.0
|
Announcement Date
|
3/27/20
|
2/3/21
|
2/3/22
|
2/3/23
|
2/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
---|
Net sales
1 |
7,930
|
9,294
|
5,504
|
5,172
|
12,072
|
7,125
|
5,138
|
7,421
|
12,559
|
6,431
|
7,423
|
13,854
|
6,857
|
9,000
|
16,500
|
8,500
|
8,000
|
16,500
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
857
|
1,214
|
739
|
571
|
1,502
|
1,296
|
973
|
1,485
|
2,458
|
1,164
|
1,674
|
2,838
|
1,320
|
1,900
|
3,400
|
1,800
|
1,600
|
3,400
|
Operating Margin
|
10.81%
|
13.06%
|
13.43%
|
11.04%
|
12.44%
|
18.19%
|
18.94%
|
20.01%
|
19.57%
|
18.1%
|
22.55%
|
20.49%
|
19.25%
|
21.11%
|
20.61%
|
21.18%
|
20%
|
20.61%
|
Earnings before Tax (EBT)
|
732
|
1,172
|
707
|
561
|
1,440
|
1,274
|
929
|
-
|
2,585
|
1,055
|
-
|
-
|
1,259
|
-
|
-
|
-
|
-
|
-
|
Net income
|
465
|
801
|
485
|
408
|
1,016
|
915
|
675
|
-
|
1,844
|
729
|
-
|
-
|
875
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
5.86%
|
8.62%
|
8.81%
|
7.89%
|
8.42%
|
12.84%
|
13.14%
|
-
|
14.68%
|
11.34%
|
-
|
-
|
12.76%
|
-
|
-
|
-
|
-
|
-
|
EPS
|
91.36
|
157.2
|
95.08
|
80.05
|
199.3
|
179.6
|
132.5
|
-
|
361.8
|
143.0
|
-
|
-
|
171.8
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
40.00
|
50.00
|
-
|
-
|
75.00
|
-
|
-
|
-
|
110.0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/29/20
|
7/28/21
|
10/27/21
|
4/26/22
|
7/27/22
|
10/27/22
|
4/27/23
|
7/27/23
|
7/27/23
|
10/26/23
|
2/7/24
|
2/7/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
1,965
|
2,503
|
5,644
|
7,751
|
9,064
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
555
|
-144
|
-
|
96
|
2,338
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
4.9%
|
5.3%
|
6.7%
|
9.1%
|
12%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
6.81%
|
6.96%
|
8.34%
|
10.5%
|
13.4%
|
-
|
-
|
-
|
Assets
1 |
17,491
|
19,300
|
21,259
|
24,366
|
27,351
|
-
|
-
|
-
|
Book Value Per Share
2 |
4,847
|
5,037
|
5,322
|
5,732
|
6,257
|
6,890
|
7,355
|
7,898
|
Cash Flow per Share
|
500.0
|
520.0
|
640.0
|
858.0
|
1,107
|
-
|
-
|
-
|
Capex
|
2,066
|
2,528
|
3,230
|
2,048
|
2,031
|
-
|
-
|
-
|
Capex / Sales
|
12.26%
|
14.99%
|
15.87%
|
8.01%
|
7.69%
|
-
|
-
|
-
|
Announcement Date
|
3/27/20
|
2/3/21
|
2/3/22
|
2/3/23
|
2/7/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +114.67% | 615M | | +2.80% | 103B | | +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +3.89% | 32.41B | | +6.82% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|